[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361711-105":59,"doc-detail-361711-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","to-describe-the-subsets-of-malignant-epithelial-cells-in-gastric-cancer-their-developmental-trajectories-and-drug-resistance-characteristics-discover-oncology","To describe the subsets of malignant epithelial cells in gastric cancer, their developmental trajectories and drug resistance characteristics - Discover Oncology","","Gastric cancer is an aggressive malignancy marked by substantial clinical heterogeneity from complex genetic and environmental interactions. Using single-cell RNA sequencing with the 10× Genomics platform, 262,532 cells were profiled from gastric cancer samples, revealing 32 clusters and 10 major cell types, including immune cells and epithelial subpopulations. Five malignant epithelial subpopulations were defined by distinct marker genes. Trajectory, cell–cell communication, and differential expression analyses linked stem-like traits, dynamic microenvironment interactions, and candidate genes to therapeutic resistance and recurrence. A prognostic risk score model using LDHA, GPC3, MIF, CD44, and TFF3 showed strong survival prediction with AUCs of 0.77, 0.77, and 0.76 across 1-, 3-, and 5-year outcomes, supported by independent cohort validation.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/to-describe-the-subsets-of-malignant-epithelial-cells-in-gastric-cancer-their-developmental-trajectories-and-drug-resistance-characteristics-discover-oncology/361711/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/to-describe-the-subsets-of-malignant-epithelial-cells-in-gastric-cancer-their-developmental-trajectories-and-drug-resistance-characteristics-discover-oncology/361711.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What experimental approach was used to study gastric cancer cells?","Question",{"text":113,"@type":114},"The study used single-cell RNA sequencing with the 10× Genomics platform to analyze 262,532 cells from gastric cancer samples.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How many malignant epithelial subpopulations were identified?",{"text":118,"@type":114},"Among epithelial subgroups, five malignant epithelial subpopulations were identified, each characterized by unique marker gene expressions.",{"name":120,"@type":111,"acceptedAnswer":121},"What is the prognostic risk model based on?",{"text":122,"@type":114},"Key genes (LDHA, GPC3, MIF, CD44, and TFF3) were used to construct a prognostic risk score model predicting overall survival.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},361711,1790180230,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Analysis  \nTo describe the subsets of malignant epithelial cells in gastric cancer, their developmental trajectories and drug resistance characteristics  \nTingting Xu1 · Tianying Zhang2 · Yan Sun2 · Sijia Wu2  \nReceived: 14 August 2024 / Accepted: 17 December 2024  \n© The Author(s) 2025 OPEN  \nAbstract  \nGastric cancer is an aggressive malignancy characterized by significant clinical heterogeneity arising from complex genetic and environmental interactions. This study employed single-cell RNA sequencing, using the 10 × Genomics platform, to analyze 262,532 cells from gastric cancer samples, identifying 32 distinct clusters and 10 major cell types, including immune cells (e.g., T cells, monocytes) and epithelial subpopulations. Among 27 epithelial subgroups, five malignant subpopulations were identified, each defined by unique marker gene expressions and playing diverse roles in tumor progression. Developmental trajectory analysis revealed potential stem-like characteristics in certain clusters, suggesting their involvement in therapeutic resistance and disease recurrence. Cell–cell communication analysis uncovered a dynamic network of interactions within the tumor microenvironment, potentially influencing tumor growth and metastasis. Differential gene expression analysis identified key genes (LDHA, GPC3, MIF, CD44, and TFF3) that were used to construct a prognostic risk score model. This model demonstrated robust predictive power, achieving AUC values of 0.77, 0.77, and 0.76 for 1-, 3-, and 5-year overall survival in the TCGA training dataset, with validation across independent cohorts. These findings deepen our understanding of gastric cancer’s cellular and molecular heterogeneity, offering insights into potential therapeutic targets and biomarkers. By facilitating the development of targeted therapies and personalized treatment strategies, these results hold promise for improving clinical outcomes in gastric cancer patients.  \nKeywords Gastric cancer · Single-cell RNA sequencing · Malignant epithelial cell subpopulations · Tumor microenvironment dynamics · Prognostic biomarkers  \n1 Introduction  \nGastric cancer remains one of the most prevalent and deadly malignancies worldwide, characterized by its aggressive nature and high mortality rate [1–3] . Despite advancements in diagnostic techniques and treatment modalities, the prognosis for gastric cancer patients, especially those diagnosed at advanced stages, remains dismal [4, 5]. The complexity of gastric cancer, driven by its heterogeneous nature and the intricate interplay of genetic, environmental, and lifestyle factors, poses significant challenges for effective management and treatment [6–8] .  \nThe etiology of gastric cancer is multifactorial, with Helicobacter pylori infection recognized as a major risk factor [9, 10]. Other contributing factors include dietary habits, smoking, alcohol consumption, and genetic predispositions [11, 12]. The disease’s progression from pre-neoplastic lesions to invasive cancer involves a multitude of genetic alterations  \n* Tingting Xu, [15008242422@163.com](15008242422@163.com); Tianying Zhang, [1292556214@qq.com](1292556214@qq.com); Yan Sun, [2774940953@qq.com](2774940953@qq.com); Sijia Wu, 3546948688@ [qq.com |](qq.com |1Department of Gastroenterology)[1](qq.com |1Department of Gastroenterology)[Department of Gastroenterology](qq.com |1Department of Gastroenterology), West China Hospital, Sichuan University, Chengdu, China. 2West China School of Medicine, Sichuan University, Chengdu, China.  \nDiscover Oncology  \n(2025) 16:93  \n| [https://doi.org/10.1007/s12672-024-01715-5](https://doi.org/10.1007/s12672-024-01715-5)  \nand the dysregulation of key signaling pathways [13–15]. Understanding these molecular mechanisms is crucial for the development of targeted therapies and improving patient outcomes [16] .  \nRecent advances in molecular biology and genomics have ushered in a new era of cancer research, enabling the detailed characterizat","cbCairAaQMA1XzLv","https://ap.wps.com/l/cbCairAaQMA1XzLv","pdf",14767091,17,"English","# Abstract\n# Keywords\n# 1 Introduction","[{\"question\":\"What experimental approach was used to study gastric cancer cells?\",\"answer\":\"The study used single-cell RNA sequencing with the 10× Genomics platform to analyze 262,532 cells from gastric cancer samples.\"},{\"question\":\"How many malignant epithelial subpopulations were identified?\",\"answer\":\"Among epithelial subgroups, five malignant epithelial subpopulations were identified, each characterized by unique marker gene expressions.\"},{\"question\":\"What is the prognostic risk model based on?\",\"answer\":\"Key genes (LDHA, GPC3, MIF, CD44, and TFF3) were used to construct a prognostic risk score model predicting overall survival.\"}]","To describe the subsets of malignant epithelial cells in gastric cancer, their developmental trajectories and drug resistance characteristics - Discover Oncology | PDF",1790145351,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2900fb5c6cb1f40dc304e4cd0112aa91.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6aeb7a01d952f8229d5048cd26c335e0.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/116c0d1484bc29b5f90b7aa2fb26651c.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/423169a915df4f2a65edf97fe1fdb03f.webp",980,1301]